IP Library Granted Patent US 11,446,075
Granted Patent B2
US 11,446,075 · App. 15/846,741 · Granted Sep 20, 2022

Method and system for consistent, repeatable, and safe cryospray treatment of airway tissue

Inventors: Thomas Mulcahey (Belmont, MA); Marc Davidson (Andover, MA); Brian M. Hanley (Reading, MA); Ellen E. Sheets (Boston, MA); Wei Li Fan (Boston, MA)
Assignee: CSA Medical, Inc.
A61B18/0218A61B90/98A61B2018/00041A61B2018/00172A61B2018/00541A61B2018/00577A61B2018/00642A61B2018/00714A61B2018/00744A61B2018/00761A61B2018/00791A61B2018/00863A61B2018/00988A61B2018/0212A61B2018/0231
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,446,075
App. No.
15/846,741
Granted
Sep 20, 2022
Kind
B2
Abstract

A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.

Claims (42)

1. A system comprising:

a source of cryogen in fluid communication with a delivery device for the cryogen;

one or more valves configured to adjust a flow of the cryogen from the source through the delivery device in response to a control signal;

a temperature sensor disposed on the delivery device; and

a controller configured to:

receive temperature information from the temperature sensor;

determine a single dose quantity of the flow of the cryogen based on the temperature information; and

adjust the control signal to the one or more valves based on the determined single dose quantity of the flow of the cryogen to deliver the determined single dose quantity of the flow of the cryogen and to terminate the flow of the cryogen when the determined single dose quantity of the flow of the cryogen is delivered.

2. The system of claim 1 , wherein the temperature information is a rate of change of temperature of the temperature sensor measured in real time during the flow of the cryogen.

3. The system of claim 2 , wherein the controller is further configured to determine if the rate of change of temperature is within a threshold safety range.

4. The system of claim 3 , wherein the controller is further configured to adjust the control signal to terminate the flow of cryogen when the rate of change of the temperature is not within the threshold safety range.

5. The system of claim 1 , wherein the controller is further configured to receive a user input of at least one location for treatment and to compare the temperature information received from the temperature sensor to a threshold temperature that is based upon the at least one location for treatment.

6. The system of claim 1 , wherein the controller is further configured to measure an elapsed time of the flow of the cryogen from the one or more valves through the delivery device, and compare the elapsed time to a threshold time.

7. The system of claim 1 , wherein the temperature information is a cooling power measurement indicative of a cooling power of the delivery device while the delivery device is delivering the flow of the cryogen; and

wherein the controller is further configured to:

receive a pressure measurement of the source of the cryogen corresponding to the cooling power measurement indicative of the cooling power of the delivery device; and

store the pressure measurement as a target pressure.

8. A system comprising:

a source of cryogen in fluid communication with a delivery device for the cryogen;

one or more valves configured to adjust a flow of the cryogen from the source through the delivery device in response to a control signal; and

a controller configured to:

determine a target single dose quantity of the flow of the cryogen;

measure an amount of the cryogen that has been delivered during the flow of the cryogen as a proportion of the target single dose quantity of the flow of the cryogen; and

control the control signal based on the target single dose quantity of the flow of the cryogen and the measured amount of the cryogen to deliver the target single dose quantity of the flow of the cryogen.

9. The system of claim 8 , wherein the controller is further configured to control the control signal to terminate the flow of the cryogen when the amount of the cryogen measured substantially matches the target single dose quantity of the flow of the cryogen.

10. The system of claim 8 , wherein the amount of the cryogen measured is a function of an amount of time elapsed at a certain rate of the flow of the cryogen.

11. The system of claim 8 , wherein the controller is further configured to record a partial delivery of the target single dose quantity of the flow of the cryogen when the amount of the cryogen measured is less than the target single dose quantity of the flow of the cryogen and greater than zero.

12. The system of claim 8 , wherein the controller is further configured to record that no flow of the cryogen was delivered when the amount of the cryogen measured is substantially zero.

13. The system of claim 11 , wherein the controller is further configured to control the control signal to continue the flow of cryogen against the target single dose quantity of the flow of the cryogen when the amount of the cryogen measured is less than the target single dose quantity of the flow of the cryogen.

14. The system of claim 8 , wherein the target single dose quantity of the flow of the cryogen is based on a user input.

15. The system of claim 14 , wherein the user input includes an identified segment of an airway.

16. A system comprising:

a delivery device for delivering a spray of a cryogen for treatment of at least one spray location;

a source of the cryogen in fluid communication with the delivery device; and

a controller comprising a user interface, the controller configured to:

receive an input from a user of a patient-type identification and the at least one spray location prior to the treatment, a single dose quantity of the cryogen determinable from the input;

control a flow of the cryogen from the delivery device during the treatment at the at least one spray location; and

determine when the treatment at the at least one spray location should be terminated based on a measured quantity of the flow of the single dose quantity of cryogen.

17. The system of claim 16 , wherein the determination is based on a treatment plan associated with the patient-type identification.

18. The system of claim 16 , wherein the determination is based on the at least one spray location.

19. The system of claim 16 , wherein the at least one spray location comprises an anatomic region and an anatomic sub-region.

20. The system of claim 16 , wherein the controller is further configured to alter a patient record to indicate a status of the treatment performed.

Assignments (6)
SECURITY INTEREST Recorded Apr 28, 2023
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; MATHERS ASSOCIATES; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATANIEL T.; HERMANN, TIM VON; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 063474/0974 →
SECURITY INTEREST Recorded Nov 3, 2021
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; NATIONAL FINANCIAL SERVICES/ FIDELITY INVESTMENTS CUSTODIAN FBO STEVEN E. SCHAEFER IRA; BROWN, DAVID; HERRMANN, TOM VON; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 058006/0451 →
SECURITY INTEREST Recorded Mar 13, 2020
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; MATHERS ASSOCIATES; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; SYMARK LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A; MWK TRUST, MIRIAM WINDER-KELLY TTE; SCHWARZ, RICHARD T; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; MELITA, TOM; VICTOIRE G. RANKIN TRUST
Reel/Frame 052105/0773 →
SECURITY INTEREST Recorded Dec 10, 2019
From: CSA MEDICAL, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 051227/0731 →
SECURITY INTEREST Recorded Oct 22, 2018
From: CSA MEDICAL, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 047261/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2018
From: MULCAHEY, THOMAS; DAVIDSON, MARC; HANLEY, BRIAN M.; SHEETS, ELLEN E.; FAN, WEI LI
To: CSA MEDICAL, INC.
Reel/Frame 045090/0858 →
Continuity (5)
Continuation 14809826 · Jul 27, 2015
Continuation 14731359 · Jun 4, 2015
Provisional Application 62007518 · Jun 4, 2014
Provisional Application 62047936 · Sep 9, 2014
Related Publication 20180110556A1 · Apr 26, 2018